CompoAtlas

Female Multi Forte

Natural health product licensed in Canada

Licence holder
Health Icon Corporation
NPN or DIN-HM
80077963
Status
Active licence
Licence date
1 June 2017
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Cuivre

Source : Citrate de cuivre (II)

800 microgrammesNot calculated
Magnésium

Source : Oxyde de magnésium

60 milligramme60,000 µg
Fer

Source : Citrate de fer (II)

15 milligramme15,000 µg
Vitamine B12

Source : Cyanocobalamine

2.6 microgrammesNot calculated
Folate

Source : Acide folique

400 microgrammesNot calculated
Vitamine B6

Source : Chlorhydrate de pyridoxine

1.2 milligramme1,200 µg
Vitamine D

Source : Cholécalciférol

15 microgrammesNot calculated
Zinc

Source : Oxyde de zinc

8 milligramme8,000 µg
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : Coenzyme Q10

50 milligrammeNot calculated
L-arginine

Source : Monohydrochlorure de L-arginine

100 milligrammeNot calculated
Trans-resvératrol

Source : Resvératrol

15 milligrammeNot calculated

Non-medicinal ingredients

Dioxyde de titane, Bleu FD&C n° 1, Dioxyde de silicium, Glycolate d'amidon sodique, Poly(éthylène glycol), Rouge FD&C N° 40, Croscarmellose de sodium, Cochenille, Teinte, Hydroxypropylcellulose, Phosphate dicalcique, Hypromellose, Cellulose, Poly(alcool vinylique), Laque d'aluminium jaune FD&C No. 6, Poly(dextrose), Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultes de sexe fémininNot specifiedminimum: 1 Comprimé ; maximum: 1 Compriméminimum: 1 day ; maximum: 1 day

Uses authorised in Canada

Helps to support normal early fetal development. Helps to support normal early development of the fetal brain and spinal cord. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps to form red blood cells and helps in their proper function. Helps in energy metabolism and in tissue formation. Helps in the normal function of the immune system. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. Helps in energy metabolism, tissue formation and bone development. Helps to maintain proper muscle function, including the heart muscle. Source of/An electrolyte for the maintenance of good health. Helps to reduce tiredness and fatigue caused by iron deficiency anemia. Helps to maintain normal DNA synthesis. Helps to maintain normal acid-base metabolism. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain the body's ability to metabolize nutrients. Helps to produce and repair connective tissue. Helps to maintain normal iron transport in the body. Helps to maintain and/or support cardiovascular health. Provides antioxidants. L-Arginine is a non-essential amino acid that is involved in protein synthesis. An antioxidant for the maintenance of good health. Multi-vitamin and multi-mineral supplement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80077963

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line